Market Research Logo

»»»

mHealth and Home Monitoring – 7th Edition

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $1,800 250 Pages Berg Insight December, 2015 BRG5789460
Lowest Prices Guaranteed
Price from $1,800
Length 250 Pages
Publisher Berg Insight
Published Date December, 2015
SKU BRG5789460
$2,700
$1,800
$5,400
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093

mHealth and Home Monitoring – 7th Edition

mHealth and Home Monitoring is the seventh consecutive report from Berg Insight that gives first-hand insights into the adoption of wireless solutions for health monitoring.

This strategic research report from Berg Insight provides you with 250 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

This report will allow you to:

Profit from 40 new executive interviews with market leading companies.
Study the strategies of 108 key players in the mHealth ecosystem.
Learn about key home health monitoring devices and services.
Understand the dynamics of the health monitoring market in Europe and North America.
Comprehend how wireless technology can become seamlessly integrated with medical devices.
Evaluate the business opportunities in the emerging mHealth segment.
Predict future market and technology developments.

This report answers the following questions:

Which medical conditions offer the best potential for wireless health monitoring solutions?
Who are the leading providers of connected medical devices?
What are the mHealth strategies of medical device vendors and pharmaceutical companies?
Which are the general technology trends for home health monitoring equipment?
What initiatives have been taken by the leading players in the telecom and IT industries?
How can connectivity redefine the use cases of medical devices and the value propositions to patients and other stakeholders?
What are the market shares of the top 5 integrated telehealth solution vendors?
Why are smartphone applications so significant for the mHealth market?
How can healthcare providers and payers benefit from mHealth solutions?


Executive summary

The number of remotely monitored patients grew by 51 percent to 4.9 million in 2015 as the market entered a growth phase fuelled by rising market acceptance in several key verticals. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Connected medical devices used for various forms of personal health tracking are not included in this figure. Berg Insight estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 48.9 percent to reach 36.1 million by 2020. Cellular connectivity has already replaced PSTN and LAN as the de-facto standard communication technology for most types of connected home medical monitoring devices and will account for 19.2 million connections in 2020. Using patients’ own mobile devices as health hubs is now becoming a viable alternative for remote patient monitoring. BYOD connectivity will be preferred by select patient groups and will be used for the remote monitoring of 15.2 million patients in 2020.

Berg Insight estimates that revenues for remote patient monitoring (RPM) solutions reached €_6.2 billion in 2015, including revenues from medical monitoring devices, mHealth connectivity solutions, care delivery platforms and mHealth care programs. RPM revenues are expected to grow at a CAGR of 32.1 percent between 2015 and 2020 to reach € 25.0 billion at the end of the forecast period. Connected medical devices accounted for 71.0 percent of total RPM revenues in 2015. However, revenues for mHealth connectivity solutions, care delivery platforms and mHealth care programs are growing at a faster rate and will account for 46.3 percent of total revenues in 2020, up from just 29.0 percent in 2015.

There is a strong trend towards incorporating more connectivity in medical devices and pharmaceuticals in order to enable new services and value propositions. Implantable cardiac rhythm management (CRM) has traditionally been the largest market segment, led by companies such as Medtronic, Biotronik and St Jude Medical that included connectivity in CRM solutions more than a decade ago. However, the sleep therapy segment is growing at the fastest rate and will surpass CRM in 2016. The number of remotely monitored sleep therapy patients grew by 170 percent in 2015, with market growth mainly driven by the vendor ResMed that has made connected healthcare a cornerstone of its strategy. Berg Insight predicts that three of the fastest growing market segments in the next five years will be glucose monitoring, air flow monitoring and connected pharmaceuticals. Today, the leading connected healthcare players in these segments include forward-thinking incumbents as well as innovative new entrants such as AstraZeneca, Dexcom, Merck, Novartis, Propeller Health, Proteus Digital Health, Roche, Sanofi, Voluntis and WellDoc.

Care delivery platforms and mHealth connectivity solutions are two of the most rapidly developing parts of the mHealth technology value chain. Care delivery platforms are software solutions that enable the remote delivery of healthcare services and allow care efforts to be coordinated between patients, various professional caregivers and other stakeholders such as the patient’s family. Care delivery platforms will be instrumental for engaging patients in their own care and delivering remote monitoring services to a large number of people in a cost efficient way. There are various types of care delivery platforms available on the market. General-purpose platforms can be adapted to a wide variety of use cases and are often used as the foundation for developing therapeutic area specific mHealth products. Companies that specialize in this area include BePatient, Exco InTouch, Medixine, OpenTeleHealth and Vivify Health. mHealth connectivity solutions include products and services that are used for collecting data from medical monitoring devices, transmitting this data to caregivers and enabling the data to be used by care delivery platforms. The leading players include Qualcomm Life, eDevice, Tactio Health, Validic and MedM.

The adoption of remote patient monitoring solutions is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. However, there are a number of barriers, including resistance to change among healthcare organizations and clinicians, misaligned incentive structures and the financing of wireless solutions by what is at large an underfunded healthcare sector. Several catalysts are nevertheless speeding up the rate of adoption – in particular incentives from payers and insurance companies, national health systems that support remote monitoring and a shift to performance-based payment models.

About the Authors

Johan Fagerberg is co-founder and an experienced analyst with a Master’s degree in Electrical Engineering from Chalmers University of Technology. He has during the past 20 years published numerous articles and reports about location-based services and wireless M2M markets.

Lars Kurkinen is a Senior Analyst with a Master’s degree in Strategic Management from the Aalto University School of Science and Technology, Finland. He joined Berg Insight in 2010 and his areas of expertise include wireless M2M verticals including mHealth, retail and smart homes.

Executive summary
1 The challenge from welfare diseases
1.1 Introduction
1.1.1 The ageing world population
1.1.2 Metabolic syndrome and lifestyle related diseases
1.2 Common chronic diseases
1.2.1 Cardiac arrhythmia
1.2.2 Ischemic diseases
1.2.3 Hypertension
1.2.4 Sleep apnea
1.2.5 Chronic respiratory diseases
1.2.6 Diabetes
1.2.7 Hyperlipidemia
1.3 Healthcare providers and reimbursement systems
1.3.1 Healthcare in Asia-Pacific
1.3.2 Healthcare in Europe
1.3.3 Healthcare in North America
1.4 Regulatory environment
1.4.1 Regulatory environment in Europe
1.4.2 Regulatory environment in the US
1.4.3 Regulatory environment in other major markets
1.4.4 International standardisation
2 mHealth platforms
2.1 Overview of the mHealth market
2.1.1 mHealth market segments
2.1.2 Connectivity options for medical devices
2.1.3 The mHealth technology value chain
2.2 mHealth connectivity solutions
2.2.1 Apple HealthKit
2.2.2 PTC
2.2.3 eDevice
2.2.4 Ericsson
2.2.5 KORE
2.2.6 Microsoft HealthVault
2.2.7 Orange Healthcare
2.2.8 Qualcomm Life
2.2.9 MedM
2.2.10 Telenor Connexion
2.2.11 Vodafone
2.3 mHealth care delivery platforms
2.3.1 AT&T
2.3.2 BePatient
2.3.3 Domicalis
2.3.4 Exco InTouch
2.3.5 Get Real Health
2.3.6 HealthyCircles
2.3.7 Medixine
2.3.8 OpenTeleHealth
2.3.9 S3 Group
2.3.10 Tactio Health
2.3.11 Verklizan
3 Physiological monitoring solution providers
3.1 Medical devices and remote monitoring
3.1.1 Medical device revenues by market segment
3.1.2 Overview of the remote patient monitoring market
3.2 Cardiac rhythm management
3.2.1 Overview of the CRM device market
3.2.2 Use cases for CRM monitoring
3.2.3 Remote monitoring solution providers
3.2.4 Biotronik
3.2.5 Boston Scientific
3.2.6 Medtronic
3.2.7 LivaNova
3.2.8 St. Jude Medical
3.3 Remote ECG monitoring
3.3.1 Overview of the remote ECG monitoring device market
3.3.2 Use cases for remote ECG monitoring
3.3.3 Remote monitoring solution providers
3.3.4 Aerotel Medical Systems
3.3.5 AliveCor
3.3.6 BioTelemetry
3.3.7 CardioComm Solutions
3.3.8 LifeWatch
3.3.9 ScottCare
3.3.10 TZ Medical
3.3.11 Zenicor
3.4 Blood pressure monitoring
3.4.1 Overview of the blood pressure monitoring device market
3.4.2 Use cases for blood pressure monitoring
3.4.3 Remote monitoring solution providers
3.4.4 Omron Healthcare
3.4.5 A&D Medical
3.4.6 Microlife
3.4.7 Rossmax
3.4.8 Sotera Wireless
3.5 Coagulation monitoring
3.5.1 Overview of the coagulation monitoring device market
3.5.2 Use cases for blood coagulation monitoring
3.5.3 Remote monitoring solution providers
3.5.4 Accriva Diagnostics
3.5.5 Alere
3.5.6 CoaguSense
3.5.7 Helena Laboratories
3.5.8 iLine Microsystems
3.5.9 Siemens Healthcare Diagnostics
3.5.10 Roche Diagnostics
3.6 Sleep therapy monitoring
3.6.1 Overview of the sleep therapy device market
3.6.2 Use cases for sleep therapy monitoring
3.6.3 Remote monitoring solution providers
3.6.4 Fisher & Paykel Healthcare
3.6.5 Philips Respironics
3.6.6 ResMed
3.6.7 SRETT
3.6.8 SomnoMed
3.6.9 Weinmann
3.7 Home sleep diagnostics
3.7.1 Overview of the home sleep diagnostics market
3.7.2 Use cases for home sleep diagnostics
3.7.3 Remote monitoring solution providers
3.7.4 Cadwell Laboratories
3.7.5 CareFusion
3.7.6 Compumedics
3.7.7 Infoscan
3.7.8 Natus Medical
3.7.9 NovaSom
3.7.10 SleepMed
3.8 Blood oxygen monitoring
3.8.1 Overview of the blood oxygen monitoring device market
3.8.2 Use cases for blood oxygen monitoring
3.8.3 Remote monitoring solution providers
3.8.4 ChoiceMMed
3.8.5 Masimo
3.8.6 Nonin Medical
3.9 Air flow monitoring
3.9.1 Overview of the air flow monitoring device market
3.9.2 Use cases for air flow monitoring
3.9.3 Remote monitoring solution providers
3.9.4 Aerocrine
3.9.5 AstraZeneca
3.9.6 Clement Clarke International
3.9.7 iSonea
3.9.8 Medical International Research
3.9.9 Ndd Medizintechnik
3.9.10 nSpire Health
3.9.11 Propeller Health
3.9.12 Sibelmed
3.9.13 Vitalograph
3.10 Glucose level monitoring
3.10.1 Overview of the glucose monitoring device market
3.10.2 Use cases for glucose monitoring
3.10.3 Remote monitoring solution providers
3.10.4 Abbott
3.10.5 Bayer Healthcare
3.10.6 BodyTel
3.10.7 Johnson & Johnson
3.10.8 Roche Diabetes Care
3.10.9 Dexcom
3.10.10 Voluntis
3.10.11 Telcare
3.10.12 WellDoc
3.11 Other
3.11.1 Implantable medical devices
3.11.2 Home hemodialysis
3.11.3 Telerehabilitation
4 Medication and integrated monitoring solution providers
4.1 Telehealth and multiparameter monitoring solutions
4.1.1 Overview of the telehealth solutions market
4.1.2 Use cases for telehealth solutions
4.1.3 Telehealth solution providers
4.1.4 Optum
4.1.5 AuthentiDate
4.1.6 Bosch Healthcare
4.1.7 Cardiocom
4.1.8 Care Innovations
4.1.9 H2AD
4.1.10 Honeywell Life Care Solutions
4.1.11 Ideal Life
4.1.12 Medvivo
4.1.13 Philips Hospital to Home
4.1.14 SHL Telemedicine
4.1.15 Telefónica
4.1.16 Tunstall Healthcare Group
4.1.17 Vitaphone
4.2 Medication compliance monitoring
4.2.1 Overview of the medication compliance monitoring market
4.2.2 Use cases for medication compliance monitoring
4.2.3 Compliance monitoring solution providers
4.2.4 DayaMed
4.2.5 Evondos
4.2.6 InRange Systems
4.2.7 Medicpen
4.2.8 Merck
4.2.9 Compliance Meds Technologies
4.2.10 MedSignals
4.2.11 Philips Medido
4.2.12 Proteus Digital Health
5 Market analysis and forecasts
5.1 Market forecasts
5.1.1 Cardiac rhythm management
5.1.2 Sleep therapy
5.1.3 Telehealth and multiparameter monitoring
5.1.4 ECG monitoring
5.1.5 Glucose level monitoring
5.1.6 Medication compliance monitoring
5.1.7 Other medical devices
5.2 Revenue forecasts
5.2.1 Medical monitoring devices
5.2.2 mHealth connectivity solutions
5.2.3 Care delivery platforms
5.2.4 mHealth care programs
5.3 Industry trends and analysis
5.3.1 New players enter the market
5.3.2 Pharmaceutical companies prepare large-scale rollouts
5.3.3 Consumerisation of medical-grade mHealth devices and apps
5.3.4 BYOD is becoming a viable option
5.3.5 Digitalisation of PSTN networks
5.3.6 Modularization of the value chain
5.4 Market drivers and barriers
5.4.1 An ageing population
5.4.2 Increasing welfare disease prevalence
5.4.3 Focus on disease prevention
5.4.4 Substitutes to medical monitoring
5.4.5 Resistance to change
5.4.6 Alignment of financial incentives
5.5 Potential market catalysts
5.5.1 Increased monitoring during clinical trials
5.5.2 Incentives from insurance companies and payers
5.5.3 National health systems support remote monitoring
5.5.4 New clinical evidence on cost effectiveness
5.5.5 Non-prescribed monitoring and healthcare consumerism
Glossary
Index
List of Figures
Figure 1.1: Population by age group (EU, North America and Japan 2015–2030)
Figure 1.2: Direct and indirect costs of chronic welfare diseases in the US and EU
Figure 1.3: Number of people suffering from chronic welfare diseases (EU/US 2008)
Figure 1.4: Percentage of population diagnosed with chronic welfare diseases
Figure 1.5: Total and per capita healthcare spending by country (2013)
Figure 1.6: Healthcare expenditure per capita by country (World 2013)
Figure 1.7: Share of population covered by private health insurance by country
Figure 1.8: Healthcare spending by type of service and product (US 2013)
Figure 2.1: mHealth market segments
Figure 2.2: Connected medical devices and the provision of care
Figure 2.3: Overview of the mHealth technology value chain
Figure 2.4: Main focus areas of mHealth connectivity solution providers
Figure 2.5: HealthGO+ and HealthGO Mini by eDevice
Figure 2.6: Examples of HealthVault-certified devices
Figure 2.7: MedM mobile applications
Figure 2.8: Examples of mHealth software products and platforms
Figure 2.9: BP eHealth Platform patient dashboard
Figure 2.10: Medixine Suite
Figure 3.1: Medical device market revenues by segment (World 2014–2020)
Figure 3.2: Connected medical devices by segment (World 2015)
Figure 3.3: Implantable cardiac rhythm management vendor market shares (2014)
Figure 3.4: Examples of implantable CRM devices
Figure 3.5: Examples of remote monitoring devices
Figure 3.6: Market shares for remote monitoring of CRM implants (2015)
Figure 3.7: CardioMessenger devices
Figure 3.8: Latitude NXT Wave wireless communicator
Figure 3.9: The Merlin.net interface and Merlin@Home transmitter
Figure 3.10: The Infinity DBS System
Figure 3.11: MCT sensor and monitor from CardioNet
Figure 3.12: Implantable loop recorder from Medtronic
Figure 3.13: AliveCor Mobile ECG third generation
Figure 3.14: AliveCor’s AliveECG app
Figure 3.15: HeartCheck devices from CardioComm Solutions
Figure 3.16: Blood pressure monitor from Omron Healthcare
Figure 3.17: Sleep therapy vendor market shares (2014)
Figure 3.18: ResMed S9 CPAP device with FX Series masks
Figure 3.19: Connected sleep therapy solutions by vendor (2015)
Figure 3.20: DreamMapper mobile application
Figure 3.21: ResMed myAir
Figure 3.22: SRETT T4P and TeleOx
Figure 3.23: Weinmann prisma25S sleep therapy device
Figure 3.24: Examples of home sleep diagnostics companies and products
Figure 3.25: iSpO2 and MightySat device and application
Figure 3.26: Turbu+ inhaler sensor and app
Figure 3.27: iSonea’s device and asthma management app
Figure 3.28: Propeller Health’s asthma management app and inhaler sensor
Figure 3.29: Blood glucose meter vendor market shares (2014)
Figure 3.30: CGM and insulin delivery system vendor market shares (2014)
Figure 3.31: Medication usage by diabetes patients (US 2011)
Figure 3.32: Glucose meters from LifeScan and Roche
Figure 3.33: Dexcom G4 CGM system
Figure 3.34: Asante Pearl insulin pump
Figure 3.35: Examples of connected blood glucose meters
Figure 3.36: Examples of connected CGM and insulin pump systems
Figure 3.37: FreeStyle Libre Flash glucose meter
Figure 3.38: Roche Accu-Chek Connect app
Figure 3.39: Dexcom G5 app and transmitter
Figure 3.40: WellDoc BlueStar
Figure 4.1: Overview of the telehealth and multiparameter monitoring landscape
Figure 4.2: Installed base of telehealth hubs by region (2015)
Figure 4.3: Telehealth hub vendor market shares (2015)
Figure 4.4: Cardiocom LinkView and Omnivisor
Figure 4.5: The Health Harmony solution
Figure 4.6: The Twitoo telehealth hub
Figure 4.7: The Honeywell Genesis DM telehealth monitor with peripherals
Figure 4.8: eCareCompanion and eCareCoordinator
Figure 4.9: Compliance monitoring solution form factors
Figure 4.10: The DayaMed MedPod
Figure 4.11: The Evondos E300 Automatic Medicine Dispenser
Figure 4.12: The EMMA medication management system
Figure 4.13: The Easypod injector and the Easypod connect transmitter
Figure 4.14: The CleverCap dispenser
Figure 4.15: The Philips Medido medication dispenser
Figure 5.1: Connected home medical monitoring devices (World 2014–2020)
Figure 5.2: Connected home medical monitoring devices by region (World 2014–2020)
Figure 5.3: Connected cardiac rhythm management devices (World 2014–2020)
Figure 5.4: Connected sleep therapy devices (World 2014–2020)
Figure 5.5: Telehealth hubs (World 2014–2020)
Figure 5.6: Connected ECG monitoring devices (World 2014–2020)
Figure 5.7: Connected glucose monitoring devices (World 2014–2020)
Figure 5.8: Connected medication monitoring solutions (World 2014–2020)
Figure 5.9: Other connected medical devices (World 2014–2020)
Figure 5.10: Remote patient monitoring revenues (World 2014–2020)
Figure 5.11: Connected medical device revenues (World 2014–2020)
Figure 5.12: mHealth connectivity solution revenues (World 2014–2020)
Figure 5.13: Care delivery platform revenues (World 2014–2020)
Figure 5.14: Monitoring service revenues (World 2014–2020)
Figure 5.15: New players enter the connected care market
Figure 5.16: Examples of landmark events in 2015 for healthcare consumerisation

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Tasks